Novo Nordisk A/S (NYSE:NVO)
| 60.21 Delayed Data As of 4:00pm ET |  +0.025 / +0.04%Today’s Change | 46.47 Today|||52-Week Range 64.82 | +4.02% Year-to-Date |
NVO Regular Dividend: NVO began trading ex-dividend on 03/27/20. A $0.7874 dividend will be paid to shareholders of record as of 03/30/20.
Latest NVO News | Press Releases
No recent news for Novo Nordisk A/S.
Today’s Trading
| Previous close | 60.18 |
| Today’s open | 60.15 |
| Day’s range | 59.58 - 60.75 |
| Volume | 4,306,677 |
| Average volume (3 months) | 1,773,205 |
| Market cap | $103.0B |
Data as of 4:00pm ET, 03/31/2020
Growth & Valuation
| Earnings growth (last year) | -2.68% |
| Earnings growth (this year) | +12.43% |
| Earnings growth (next 5 years) | +10.73% |
| Revenue growth (last year) | +3.34% |
| P/E ratio | 25.1 |
| Price/Sales | 7.53 |
| Price/Book | 15.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | +1.03 | +1.37% |
| SNYSanofi | -1.10 | -2.45% |
| AZNAstraZeneca | +0.15 | +0.34% |
| BMYBristol-Myers Squibb | +1.36 | +2.50% |
Data as of 4:59pm ET, 03/31/2020
Financials
| Next reporting date | May 6, 2020 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $18.3B |
| Annual profit (last year) | $5.8B |
| Net profit margin | 31.92% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bagsværd, Capital Region |
Forecasts
